Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Izzet Fresko

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Neurology|July 8, 2025
Central nervous system involvement and mimickers in ANCA associated vasculitisYeliz Yagiz Ozogul, Sinem Nihal Esatoglu, Murat Ozogul, et al.
Rheumatology International|November 26, 2021
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndromeGuzin Ozcifci, Tahacan Aydin, Zeynep Atli, et al.
Rheumatology (Oxford, England)|June 3, 2022
Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic reviewGuzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, et al.
Clinical Immunology (Orlando, Fla.)|June 29, 2023
Infliximab for vascular involvement in Behçet's syndromeGulen Hatemi, Nur Beyza Tukek, Sinem Nihal Esatoglu, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Rheumatology (Oxford, England)|August 7, 2024
De novo manifestations during adalimumab treatment in Behçet's syndromeSinem Nihal Esatoglu, Ozge Sonmez, Didar Ucar, et al.
Rheumatology International|July 6, 2021
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination ratesAysa Hacioglu, Sermin Borekci, Melike Melikoglu, et al.
Rheumatology (Oxford, England)|December 27, 2021
Emergence of new manifestations during infliximab treatment in Behçet's syndromeNur Beyza Tukek, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Arthritis Research & Therapy|February 8, 2012
Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in TurkeyZiver Sahin, Muge Bıcakcıgil, Kenan Aksu, et al.
Clinical and Experimental Rheumatology|January 26, 2012
PDCD1 polymorphisms are not associated with Takayasu's arteritis in TurkeyHaner Direskeneli, Ezgi Tuna-Erdoğan, Feyza Gündüz, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Neurology|July 8, 2025
Central nervous system involvement and mimickers in ANCA associated vasculitisYeliz Yagiz Ozogul, Sinem Nihal Esatoglu, Murat Ozogul, et al.
Rheumatology International|November 26, 2021
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndromeGuzin Ozcifci, Tahacan Aydin, Zeynep Atli, et al.
Rheumatology (Oxford, England)|June 3, 2022
Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic reviewGuzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, et al.
Clinical Immunology (Orlando, Fla.)|June 29, 2023
Infliximab for vascular involvement in Behçet's syndromeGulen Hatemi, Nur Beyza Tukek, Sinem Nihal Esatoglu, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Rheumatology (Oxford, England)|August 7, 2024
De novo manifestations during adalimumab treatment in Behçet's syndromeSinem Nihal Esatoglu, Ozge Sonmez, Didar Ucar, et al.
Rheumatology International|July 6, 2021
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination ratesAysa Hacioglu, Sermin Borekci, Melike Melikoglu, et al.
Rheumatology (Oxford, England)|December 27, 2021
Emergence of new manifestations during infliximab treatment in Behçet's syndromeNur Beyza Tukek, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Arthritis Research & Therapy|February 8, 2012
Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in TurkeyZiver Sahin, Muge Bıcakcıgil, Kenan Aksu, et al.
Clinical and Experimental Rheumatology|January 26, 2012
PDCD1 polymorphisms are not associated with Takayasu's arteritis in TurkeyHaner Direskeneli, Ezgi Tuna-Erdoğan, Feyza Gündüz, et al.
Pageof 6